Insurance specialty broker Ryan Specialty (NYSE: RYAN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.2% year on year to $916.6 million. Its non-GAAP profit of $0.74 per share was 22.9% above analysts’ consensus estimates.

Is now the time to buy Ryan Specialty? Find out by accessing our full research report, it’s free.

Company Overview

Founded in 2010 by insurance industry veteran Patrick Ryan, Ryan Specialty (NYSE: RYAN) is a wholesale insurance broker and underwriting manager that helps retail brokers place complex or hard-to-place risks with insurance carriers.

Revenue Growth

A company’s long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.

With $3.22 billion in revenue over the past 12 months, Ryan Specialty is a mid-sized business services company, which sometimes brings disadvantages compared to larger competitors benefiting from better economies of scale. On the bright side, it can still flex high growth rates because it’s working from a smaller revenue base.

As you can see below, Ryan Specialty’s sales grew at an incredible 20.5% compounded annual growth rate over the last five years. This is a great starting point for our analysis because it shows Ryan Specialty’s demand was higher than many business services companies.

Long-term growth is the most important, but within business services, a half-decade historical view may miss new innovations or demand cycles. Ryan Specialty’s annualized revenue growth of 18.7% over the last two years is below its five-year trend, but we still think the results suggest healthy demand.

This quarter, Ryan Specialty reported year-on-year revenue growth of 7.2%, and its $916.6 million of revenue exceeded Wall Street’s estimates by 5.3%.

Looking ahead, sell-side analysts expect revenue to grow 4.8% over the next 12 months, a deceleration versus the last two years. This projection doesn’t excite us and indicates its products and services will see some demand headwinds. At least the company is tracking well in other measures of financial health.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Adjusted Operating Margin

Adjusted operating margin is one of the best measures of profitability because it tells us how much money a company takes home after subtracting all core expenses, like marketing and R&D. It also removes various one-time costs to paint a better picture of normalized profits.

Ryan Specialty has been an efficient company over the last five years. It was one of the more profitable businesses in the business services sector, boasting an average adjusted operating margin of 16.1%.

Looking at the trend in its profitability, Ryan Specialty’s adjusted operating margin rose by 2.2 percentage points over the last five years, as its sales growth gave it operating leverage.

This quarter, Ryan Specialty generated an adjusted operating margin profit margin of 19.7%, down 2.7 percentage points year on year. This contraction shows it was less efficient because its expenses grew faster than its revenue.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Ryan Specialty’s full-year EPS grew at an astounding 16.4% compounded annual growth rate over the last four years, better than the broader business services sector.

Like with revenue, we analyze EPS over a more recent period because it can provide insight into an emerging theme or development for the business.

Ryan Specialty’s EPS grew at a remarkable 15.4% compounded annual growth rate over the last two years. This performance was better than most business services businesses.

Diving into Ryan Specialty’s quality of earnings can give us a better understanding of its performance. Ryan Specialty’s adjusted operating margin has declined over the last two years. This was the most relevant factor (aside from the revenue impact) behind its lower earnings; interest expenses and taxes can also affect EPS but don’t tell us as much about a company’s fundamentals.

In Q2, Ryan Specialty reported adjusted EPS of $0.74, up from $0.66 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Ryan Specialty’s full-year EPS to grow 4.1% from $2.13 to $2.22.

Key Takeaways from Ryan Specialty’s Q2 Results

It was good to see Ryan Specialty beat analysts’ EPS expectations this quarter. We were also excited its revenue outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 16.1% to $51.19 immediately following the results.

Ryan Specialty put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).